Word

ALVRANT

Status

Registered

Status Code

700

Status Date

Tuesday, November 26, 2019

Serial Number

79263055

Registration Number

5917460

Registration Date

Tuesday, November 26, 2019

Mark Type

4000

Filing Date

Thursday, May 16, 2019

Published for Opposition

Tuesday, September 10, 2019

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events

Feb 7, 2020

Notification Processed By Ib

Jan 23, 2020

Final Disposition Notice Sent To Ib

Jan 23, 2020

Final Disposition Processed

Dec 26, 2019

Grant Of Protection Created, To Be Sent To Ib

Nov 26, 2019

Registered-Principal Register

Sep 10, 2019

Published For Opposition

Aug 21, 2019

Notice Of Publication

Aug 6, 2019

Application Filing Receipt Mailed

Aug 5, 2019

Approved For Pub - Principal Register

Aug 1, 2019

Assigned To Examiner

Jul 31, 2019

New Application Office Supplied Data Entered In Tram

Jul 25, 2019

Limitation From Original Application Entered

Jul 18, 2019

Sn Assigned For Sect 66a Appl From Ib